Staying consumer-centric in a digital world
which included David Best, president and chief operating officer of Coborn’s Inc.; Sandy Douglas, chief executive officer of
Opinion
Five reasons regional drug chains lead the industry
On the eve of the annual NACDS regional chain conference, about to convene in South Florida as this piece is written, now is perhaps the perfect time to reflect on the stunning success regional drug chains are experiencing in the U.S. chain drug community.
Misguided policies threaten biopharmaceutical gains
The last year has been remarkable for medical advancement, and with thousands of therapies in the development pipeline, 2024 promises to be just as exciting.
It’s time to rediscover the lost art of merchandising
CVS, Rite Aid and Walgreens — succeeded as much for the zeal, creativity and accomplishments of their chief merchants as for the directions provided by their senior management. Indeed, it was a time when people like Vern Brunner, Chris Bodine and
CVS is fully capitalizing on retail media
Like most major retailers, CVS Pharmacy has entered the media business with the intent of broadening and deepening consumer engagement, working with CPG companies to better serve shoppers and grow categories, and establishing a new revenue stream.
McMillon heralds a new kind of retailing
When the history of Doug McMillon’s tenure as chief executive officer of Walmart is written, the central theme is sure to be the transformation of the company from one entrenched in brick-and-mortar retailing into a multidimensional enterprise.
An appreciation for an industry legend
as we obviously have — then it’s equally true that this is a new era for the regional chain executive. Explore the National Association of Chain Drug Stores board of directors and you’ll find that it’s well represented,
Health care outlook 2024: Steve Anderson, president, CEO, NACDS
a great friend of NACDS — stand the
A memorable occasion for NACDS, mass retailing
Viewed from almost any perspective, December 13, 2023, was a significant day in the history of mass retailing in America.
Health care outlook 2024: John O’Brien, president and CEO, NPC
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. 2023 was a pivotal year for health policy, to say the least.
Health care outlook 2024: Scott Melville, president and CEO, CHPA
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
Health care outlook 2024: Micah Cost, CEO, PQA
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Former Defense Secretary Donald Rumsfeld once observed that “there are known knowns. There are things we know we know. We also know there are known unknowns.
Health care outlook 2024: Ronald Piervincenzi, CEO, U.S. Pharmacopeia
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation.
Health care outlook 2024: Sheila Arquette, president and CEO, NASP
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive.